{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:14:20Z","timestamp":1788480860539,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejphar.2014.01.032","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T08:30:46Z","timestamp":1390984246000},"page":"125-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine"],"prefix":"10.1016","volume":"727","author":[{"given":"Luke A.","family":"Downey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Loftis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.01.032_bib1","doi-asserted-by":"crossref","first-page":"e19258","DOI":"10.1371\/journal.pone.0019258","article-title":"Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine","volume":"6","author":"Abdul Muneer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.01.032_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1326-6-23","article-title":"Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction","volume":"6","author":"Abdul Muneer","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2014.01.032_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0376-8716(03)00092-9","article-title":"Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment","volume":"71","author":"Aharonovich","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2014.01.032_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.mp.4002107","article-title":"Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse","volume":"13","author":"Berman","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.01.032_bib5","doi-asserted-by":"crossref","first-page":"e61234","DOI":"10.1371\/journal.pone.0061234","article-title":"Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users","volume":"8","author":"Bosch","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.01.032_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1530-0277.2001.tb02215.x","article-title":"Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery","volume":"25","author":"Bowden","year":"2001","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2014.01.032_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-101-4-527","article-title":"Nonenzymatic glycosylation and the pathogenesis of diabetic complications","volume":"101","author":"Brownlee","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2014.01.032_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00006231-200108000-00007","article-title":"Long-term effects of \u2018ecstasy\u2019 abuse on the human brain studied by FDG PET","volume":"22","author":"Buchert","year":"2001","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ejphar.2014.01.032_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12035-009-8064-1","article-title":"Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview","volume":"39","author":"Capela","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","article-title":"Toxicity of amphetamines: an update","volume":"86","author":"Carvalho","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2014.01.032_bib11","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/j.1360-0443.2006.01782.x","article-title":"Structural and metabolic brain changes in the striatum associated with methamphetamine abuse","volume":"102","author":"Chang","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2014.01.032_bib12","doi-asserted-by":"crossref","unstructured":"Chen, P.H., Huang, M.C., Lai, Y.C., Chen, P.Y., Liu, H.C., 2012. Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal. Addict. Biol. [Epub ahead of print] PubMed PMID: 22458544.","DOI":"10.1111\/j.1369-1600.2012.00444.x"},{"key":"10.1016\/j.ejphar.2014.01.032_bib13","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1523\/JNEUROSCI.14-04-02260.1994","article-title":"Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress","volume":"14","author":"Cubells","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.01.032_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ntt.2004.03.008","article-title":"The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats","volume":"26","author":"Darvesh","year":"2004","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.301.1.138","article-title":"3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain","volume":"301","author":"Darvesh","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.01.032_bib16","doi-asserted-by":"crossref","first-page":"11446","DOI":"10.1021\/ja047690h","article-title":"Immunological consequences of methamphetamine protein glycation","volume":"126","author":"Dickerson","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2014.01.032_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1124\/jpet.112.199745","article-title":"Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity","volume":"344","author":"Friend","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.01.032_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/bj20020825","article-title":"Protein nitration is predominantly mediated by a peroxynitrite-dependent pathway in cultured human leucocytes","volume":"367","author":"Galinanes","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2014.01.032_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","article-title":"Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG","volume":"20","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.01.032_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuint.2007.03.004","article-title":"Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) administration in awake rats","volume":"51","author":"Gramsbergen","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2014.01.032_bib22","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.01.032_bib23","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/cne.23048","article-title":"(\u00b1)3,4 methylenedioxymethamphetamine (\u201cecstasy\u201d) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain","volume":"520","author":"Hemmerle","year":"2012","journal-title":"J. Comp. Neurol."},{"issue":"Supp 1","key":"10.1016\/j.ejphar.2014.01.032_bib101","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.bbi.2012.07.114","article-title":"Methamphetamine addiction is associated with increased T-cell immunoreactivity and neuropsychiatric impairment","volume":"26","author":"Huckans","year":"2012","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.ejphar.2014.01.032_bib201","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1080\/15287390490514589","article-title":"Modulation of murine macrophage function by methamphetamine","volume":"67","author":"In","year":"2004","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.ejphar.2014.01.032_bib202","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1080\/15287390500177156","article-title":"Methamphetamine administration produces immunomodulation in mice","volume":"68","author":"In","year":"2005","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.ejphar.2014.01.032_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2131\/jts.35.375","article-title":"Recreational drugs, 3,4-Methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and diphenylprolinol, inhibit neurite outgrowth in PC12 cells","volume":"35","author":"Kaizaki","year":"2010","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2014.01.032_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jpsychires.2009.03.011","article-title":"Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers","volume":"43","author":"Kim","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2014.01.032_bib26","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/brain\/awq103","article-title":"Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography\/[11C] DASB and structural brain imaging study","volume":"133","author":"Kish","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2014.01.032_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fphar.2012.00121","article-title":"The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation","volume":"3","author":"Kousik","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib111","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.070971","article-title":"Methamphetamine enhances HIV infection of macrophages","volume":"172","author":"Liang","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejphar.2014.01.032_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12640-010-9223-x","article-title":"Methamphetamine causes persistent immune dysregulation: a cross-species, translational report","volume":"20","author":"Loftis","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2014.01.032_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pharmthera.2013.04.011","article-title":"Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy","volume":"139","author":"Loftis","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.01.032_bib30","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1046\/j.1471-4159.2000.0752040.x","article-title":"Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal","volume":"75","author":"Loftis","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.01.032_bib121","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/599328","article-title":"Methamphetamine enhances histoplasmosis by immunosuppression of the host","volume":"200","author":"Martinez","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejphar.2014.01.032_bib31","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1074\/jbc.M106393200","article-title":"Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity","volume":"277","author":"Matata","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.01.032_bib32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1189\/jlb.0108022","article-title":"The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?","volume":"84","author":"Matarese","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-008-1218-4","article-title":"Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (\u00b1) 3, 4-methylenedioxymethamphetamine (\u201cecstasy\u201d) users: relationship to cognitive performance","volume":"200","author":"McCann","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.01.032_bib131","unstructured":"National Institutes of Health, National Institute on Drug Abuse. Substance Use Disorders and Molecular Regulation of Brain Energy Utilization. 2013. http:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-DA-14-005.html."},{"key":"10.1016\/j.ejphar.2014.01.032_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0378-4274(01)00511-2","article-title":"Specific neurotoxicity of chronic use of ecstasy","volume":"127","author":"Obrocki","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2014.01.032_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2010.07.004","article-title":"Role of serotonin and\/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain","volume":"644","author":"Pachmerhiwala","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0269881106063268","article-title":"MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress","volume":"20","author":"Parrott","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib37","doi-asserted-by":"crossref","unstructured":"Peraile, I., Granado, N., Torres, E., Gutierrez-Lopez, M.D., Moratalla, R., Colado, M.I., O\u05f3Shea, E., 2013. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders. Psychopharmacol. (Berl.).","DOI":"10.1007\/s00213-013-3142-5"},{"key":"10.1016\/j.ejphar.2014.01.032_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12640-012-9350-7","article-title":"The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines","volume":"23","author":"Permpoonputtana","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2014.01.032_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1874473711306010008","article-title":"Cognitive function in ecstasy naive abstinent drug dependants and MDMA users","volume":"6","author":"Potter","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.ejphar.2014.01.032_bib40","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.4049\/jimmunol.0903691","article-title":"Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment","volume":"185","author":"Potula","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2004.08.008","article-title":"Free radical production induced by methamphetamine in rat striatal synaptosomes","volume":"204","author":"Pubill","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib42","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1208\/aapsj080238","article-title":"Causes and consequences of methamphetamine and MDMA toxicity","volume":"8","author":"Quinton","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2014.01.032_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jnc.12247","article-title":"Memory impairment and hippocampus specific protein oxidation induced by ethanol intake and 3, 4-Methylenedioxymethamphetamine (MDMA) in mice","volume":"125","author":"Ros-Simo","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.01.032_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/13803390600659384","article-title":"The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence","volume":"29","author":"Sadek","year":"2007","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib45","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/jcbfm.2009.261","article-title":"Glial dysfunction in abstinent methamphetamine abusers","volume":"30","author":"Sailasuta","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2014.01.032_bib46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1017\/S1461145712001447","article-title":"Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA","volume":"16","author":"Schaefer","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib47","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"Methamphetamine causes microglial activation in the brains of human abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.01.032_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1471-4159.2011.07418.x","article-title":"Methamphetamine exposure during brain development alters the brain acetylcholine system in adolescent mice","volume":"119","author":"Siegel","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.01.032_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FBP.0b013e3282f62c76","article-title":"Developmental effects of 3,4 methylenedioxymethamphetamine: a review","volume":"19","author":"Skelton","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/138920110791591436","article-title":"Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage","volume":"11","author":"Song","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib51","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1523\/JNEUROSCI.0713-04.2004","article-title":"Structural abnormalities in the brains of human subjects who use methamphetamine","volume":"24","author":"Thompson","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.01.032_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1742-2094-8-53","article-title":"Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity","volume":"8","author":"Torres","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.ejphar.2014.01.032_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2012.10.006","article-title":"A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine","volume":"50","author":"Urrutia","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2014.01.032_bib54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.158.3.383","article-title":"Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.01.032_bib55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.01.032_bib56","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI18533","article-title":"The addicted human brain: insights from imaging studies","volume":"111","author":"Volkow","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2014.01.032_bib57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevNeurobiol.v17.i2.30","article-title":"Amphetamine neurotoxicity: cause and consequence of oxidative stress","volume":"17","author":"Yamamoto","year":"2005","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11481-008-9121-7","article-title":"The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse","volume":"3","author":"Yamamoto","year":"2008","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2014.01.032_bib141","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2893.2007.00940.x","article-title":"Methamphetamine enhances Hepatitis C virus replication in human hepatocytes","volume":"15","author":"Ye","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejphar.2014.01.032_bib59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000351278","article-title":"Developmental methamphetamine exposure results in short- and long-term alterations in hypothalamic-pituitary-adrenal-axis-associated proteins","volume":"35","author":"Zuloaga","year":"2013","journal-title":"Dev. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:06:15Z","timestamp":1746122775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":66,"alternative-id":["S0014299914000533"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.032","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}